Reimagining Biomarkers to Illuminate the Right Patient Population & Advance Precision Medicine Impact
Time: 4:00 pm
day: Conference Day 2
Details:
- Navigating biomarkers in cardiovascular drug development that span all modalities – genetics, peripheral proteins, lipids, inflammatory markers as well as imaging and device-derived markers
- De-risking cardiovascular outcome trials with early proof of concept biomarkers remains a major challenge
- Exploratory omic analyses in cardiovascular outcomes offer hypothesis generation for precision medicine
